PRESS RELEASE published on 09/11/2024 at 14:00, 1 year 4 months ago TVM CAPITAL LIFE SCIENCE TO PARTICIPATE IN LSI EUROPE ’24 EMERGING MEDTECH SUMMIT 2024 TVM Capital Life Science to participate in LSI Europe '24 Emerging Medtech Summit 2024, showcasing partnerships and trends in healthcare technology. Key panel discussion on cross-border investors in medtech Healthcare Technology Investment TVM Capital Life Science Medtech Summit LSI Europe '24
PRESS RELEASE published on 09/11/2024 at 14:00, 1 year 4 months ago Saha Global Awarded $5 Million Grant From the Conrad N. Hilton Foundation to Expand Safe Water Access in Rural Ghana Saha Global awarded $5-million grant from Conrad N. Hilton Foundation to expand safe water access for underserved populations in Ghana Ghana Grant Saha Global Conrad N. Hilton Foundation Safe Water Access
PRESS RELEASE published on 09/11/2024 at 14:00, 1 year 4 months ago illuxi Expands Its Footprint Across Canada Illuxi, a leading provider of AI-powered learning platforms, opens new office in Toronto and appoints Vincent Bowry as National Sales and Client Success Manager, underscoring its commitment to expanding across Canada Expansion Illuxi Toronto Office Vincent Bowry AI-powered Learning
PRESS RELEASE published on 09/11/2024 at 14:00, 1 year 4 months ago illuxi étend sa présence à travers le Canada Illuxi, leader en formation par l'IA, ouvre un bureau à Toronto et nomme Vincent Bowry comme directeur des ventes et du succès client. Expansion stratégique soulignant l'engagement d'illuxi au Canada anglophone Illuxi Toronto IA Formation Vincent Bowry
PRESS RELEASE published on 09/11/2024 at 13:30, 1 year 4 months ago MIRA Pharmaceuticals Designates Neuropathic Pain as Primary Indication for Ketamir-2 and Submits Pre-IND Meeting Request to FDA MIRA Pharmaceuticals, Inc. selects neuropathic pain as the primary indication for its novel oral ketamine analog, Ketamir-2, targeting neurologic disorders. Pre-IND meeting with FDA anticipated in Nov 2024 Preclinical Studies MIRA Pharmaceuticals Ketamir-2 Neuropathic Pain FDA Meeting
PRESS RELEASE published on 09/11/2024 at 13:30, 1 year 4 months ago Nextech3D.ai Signs LOI to Acquire Designhubz Expanding its 3D & AR Portfolio With Try-On Technology For Wearables Nextech3D.AI acquires Designhubz's AR try-on technology, enhancing immersive eCommerce experiences and personalization capabilities. CEO excited about the expanded market and strategic positioning E-commerce Nextech3D.ai AR Technology Immersive Experiences Designhubz
PRESS RELEASE published on 09/11/2024 at 13:30, 1 year 4 months ago CallTower and Nuvias UC Launch Alliance in EMEA CallTower partners with Nuvias UC to expand cloud communications distribution in EMEA. The collaboration aims to enhance productivity and reach new markets Partnership Cloud Communications CallTower Nuvias UC EMEA Marketplace
PRESS RELEASE published on 09/11/2024 at 13:30, 1 year 4 months ago Electrical Geophysical Integration Reveals Upside at Piuquenes Cu–Au Porphyry Project, San Juan Pampa Metals Corp. provides update on Piuquenes Cu-Au Project in Argentina, highlighting key findings from geophysical data integration and current activities for the upcoming field season Pampa Metals Corp. Geophysical Data Argentina Field Season Piuquenes
PRESS RELEASE published on 09/11/2024 at 13:25, 1 year 4 months ago Hardman & Co Research on Shield Therapeutics (STX): Focusing on successful execution Hardman & Co Research provides analysis on Shield Therapeutics (STX) focusing on successful execution. Shield progressing well with sales traction and cost control, aiming for cashflow-break even in 2H'25 Hardman & Co Research Shield Therapeutics Iron Deficiency Successful Execution Sales Traction
PRESS RELEASE published on 09/11/2024 at 13:00, 1 year 4 months ago Santé Canada approuve (Pr)CABTREO(MC) (phosphate de clindamycine, adapalène et peroxyde de benzoyle), un traitement topique à triple combinaison pour l'acné vulgaire chez les patients âgés de 12 ans et plus Bausch Health Canada Inc. annonce l'approbation par Santé Canada de PrCABTREO, traitement topique à triple combinaison pour l'acné vulgaire. Disponible Q4 2024 Bausch Health Efficacité Santé Canada Traitement Topique Acné Vulgaire
Published on 02/02/2026 at 00:05, 10 hours 29 minutes ago Resource Upgrade Drilling Begins on Challenger Open Pits
Published on 01/31/2026 at 03:15, 2 days 7 hours ago Empress Royalty Announces Grant Of Restricted Share Units
Published on 01/31/2026 at 01:40, 2 days 8 hours ago Star Copper Announces Grant of RSUs, Stock Options and PSUs
Published on 02/02/2026 at 10:05, 29 minutes ago H55 Successfully Completes - For the First Time in the Aviation Industry - All Regulator Required Propulsion Battery Module Certification Tests
Published on 02/02/2026 at 10:05, 29 minutes ago Lenzing AG to become majority owner of TreeToTextile AB and accelerates industrialization of new fibers
Published on 02/02/2026 at 10:00, 34 minutes ago ABB introduces Automation Extended: enabling industrial innovation with continuity
Published on 02/02/2026 at 10:00, 34 minutes ago Further growth in the fourth quarter leads to annual sales of EUR 12.5 million (+2%); Important milestone achieved in antibacterial implants
Published on 02/02/2026 at 07:00, 3 hours 34 minutes ago Entech signe un contrat avec TotalEnergies pour la construction d’un système de stockage hybride éolien de 8MW/8MWh en Guadeloupe
Published on 01/30/2026 at 18:40, 2 days 15 hours ago ICADE - Bilan semestriel du contrat de liquidite